切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2020, Vol. 08 ›› Issue (02) : 112 -116. doi: 10.3877/cma.j.issn.2095-655X.2020.02.010

所属专题: 文献

临床研究

乳腺包裹性乳头状癌临床诊断学特征分析
曹卫刚1, 杨振林1,()   
  1. 1. 264100 滨州医学院烟台附属医院甲状腺乳腺外科
  • 收稿日期:2019-10-08 出版日期:2020-05-26
  • 通信作者: 杨振林
  • 基金资助:
    山东省自然科学基金(ZR2017MH033); 烟台市重点研发计划项目(2019YD063); 滨州医学院校级科技计划项目(BY2018KJ31)

Analysis of clinical diagnostic features of encapsulated papillary carcinoma of breast

Weigang Cao1, Zhenlin Yang1,()   

  1. 1. Depatment of Tyroid and Breast Surgery, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China
  • Received:2019-10-08 Published:2020-05-26
  • Corresponding author: Zhenlin Yang
  • About author:
    Corresponding author: Yang Zhenlin, Email:
引用本文:

曹卫刚, 杨振林. 乳腺包裹性乳头状癌临床诊断学特征分析[J/OL]. 中华诊断学电子杂志, 2020, 08(02): 112-116.

Weigang Cao, Zhenlin Yang. Analysis of clinical diagnostic features of encapsulated papillary carcinoma of breast[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2020, 08(02): 112-116.

目的

探讨乳腺包裹性乳头状癌(EPC)的临床诊断学特征。

方法

回顾性分析2014年1月至2018年11月滨州医学院烟台附属医院乳腺外科诊断为乳腺包裹性乳头状癌5例患者的临床影像学和病理学资料,总结其诊断学特征。

结果

EPC患者均为女性,年龄54~70岁,均因乳房肿块首诊,其中1例乳头溢液,1例乳腺疼痛;肿块最大径1.0~4.0 cm,质地韧、偏硬,表面尚光滑,活动尚可,皮肤无红肿,无酒窝征及橘皮征,腋窝无淋巴结转移。乳腺超声提示肿块为边界清晰,形态不规则的囊实性肿物;磁共振成像(MRI)提示肿块为边界清晰、囊性液体包裹的宽基底、形态不规则的高信号实性肿物。EPC病理学肉眼观察为质脆、类圆形突起的囊实性结节;镜下表现为一层厚纤维包膜围绕的乳头状增生病变,呈蓬乱分枝乳头状结构,管腔均未见肌上皮细胞,免疫组织化学染色示雌激素受体(ER)、孕激素受体(PR)均阳性,4例人类表皮生长因子受体2(Her-2)阴性,1例Her-2阳性,Ki-67%<5%,CK5/6及p63肌上皮染色呈阴性;5例均为Lunimal A型。4例患者行乳腺癌改良根治术,1例行乳腺癌保乳术,均无淋巴结转移。

结论

EPC好发于老年女性,多因乳房肿块首诊,镜下呈厚纤维包膜围绕的蓬乱分枝乳头状结构,免疫组化染色证实病变周缘肌上皮明显减少甚至缺如,是该病重要的临床诊断学特征。

Objective

To explore the clinical diagnostic features of encapsulated papillary carcinoma (EPC) of breast.

Methods

The clinical data of 5 cases of EPC in Yantai Affiliated Hospital of Binzhou Medical University from January 2014 to November 2018 were analyzed retrospectively.

Results

EPC patients were all female, aged from 54 to 70 years old. The first diagnosis was due to breast mass, including 1 case of nipple overflow and 1 case of breast pain. The maximum diameter of the mass was from 1.0 to 4.0 cm, with tough and hard texture, smooth surface, fair movement, no redness or swelling of skin, no dimple or orange skin signs, and no lymph node metastasis in axilla. Breast ultrasound showed that the mass was a solid mass with clear boundary and irregular shape, while MRI showed that the mass was a solid mass with clear boundary and wide base surrounded by cystic fluid and irregular shape. In 5 cases of EPC pathology, there were crispy, round like cystic solid nodules by perusal. Microscopic appearance: there was a layer of thick fibrous capsule surrounded by papillary hyperplasia, which presented a disordered branching papillary structure. No myoepithelial cells were found in the lumen. Immunohistochemical staining showed that estrogen receptor (ER) and progesterone receptor (PR) were all positive. In 4 cases, human epidermal growth factor receptor 2 (HER-2) was negative. In 1 case, HER-2 was positive. In all 5 cases, Ki-67%<5%, CK5/6 and p63 were negative. Four patients were treated with modified radical mastectomy and one with breast conserving surgery.

Conclusions

EPC is prone to occur in elderly women. The first diagnosis is mostly due to a breast mass. Under the microscope, it presents a messy branch papillary structure surrounded by thick fibrous capsule. Immunohistochemical staining shows that the myoepithelium around the lesion is significantly reduced or even absent. These are the important clinical diagnostic features of the disease.

表1 5 例乳腺包裹性乳头状癌患者的临床特征
图1 乳腺包裹性乳头状癌患者的病理学图像
表2 5 例乳腺包裹性乳头状癌患者的病理学特征
[1]
Wynveen CA, Nehhozina T, AkramM,et al.Intracystic papillary carcinoma of the breast: an in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up[J].Am J Surg Pathol,2011,35(1):1-14.
[2]
Lakhani SR, Ellis IO, Schnitt SJ,et al.WHO classification of tumours of the breast[M].Lyon:IARC Press,2012:90-91.
[3]
Tan PH, Schnitt SJ, van de Vijver MJ,et al.Papillary and neuroendocrine breast lesions:the WHO stance[J].Histopathology,2015,66(6):761-770.
[4]
Wolff AC, Hammond MEH, Allison KH,et al.Human epidermal growth factor receptor 2 testing in breast cancer:American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline focused update[J]. J Clin Oncol, 2018,36(20):2105-2122.
[5]
王莹,王振宇,陈国栋,等.乳腺包裹性乳头状癌诊疗新进展[J].中国老年学杂志,2017,37(12):3109-3111.
[6]
黄润生,翁立峰,石海峰.彩色多普勒超声与钼靶X线摄影检查对乳腺黏液癌的诊断价值分析[J/CD].中华诊断学电子杂志,2019,7(1):17-20.
[7]
徐玮,王丽君,虞崚崴,等.乳腺包裹性乳头状癌的MRI特点影像诊断与介入放射学[J].影响诊断与介入放射学,2018,27(2):133-138.
[8]
林瀛,杨雄华,陈小岩.乳腺包裹性乳头状癌11例临床病理分析[J].肿瘤研究与临床,2016,28(4):266-269.
[9]
熊中堂,江庆萍,刘少颜,等.乳腺包裹性乳头状癌临床病理分析[J].现代肿瘤医学,2017,25(9):1406-1409.
[10]
黄润生,翁立峰,裴蓓.乳腺黏液癌超声图像特征及误诊分析[J/CD].中华诊断学电子杂志,2018,6(2):115-118.
[11]
吕民豪,秦丽,李军涛,等.乳腺囊内乳头状癌:49例临床特征及预后分析[J].肿瘤,2016,36(8):896-900.
[12]
王顺利,邓双双,高慧,等.乳腺包裹性乳头状癌的临床和病理特征分析[J].诊断学理论和实践,2019,18(1):89-92.
[13]
陈园园,王霞,饶金,等.乳腺包裹性乳头状癌的超声和MRI影像特征分析[J].中国CT和MRI杂志,2018,16(7):32-35.
[14]
Regan JP, Casaubon JT, Genelus-Dominique E.Synchronous invasive ductal carcinoma in encapsulated papillary ductal carcinoma[J].J Surg Case Rep,2016(8):141.
[15]
Khoury T, Hu Q, Liu S,et al.Intracystic papillary carcinoma of breast: inter relationship with in situ and invasive carcinoma and a proposal of pathogenesis: array comparative genomic hybridization study of 14 cases[J].Mod Pathol,2014,27(2):194-203.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[3] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[4] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[5] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[6] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[7] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[8] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[9] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[13] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[14] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[15] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
阅读次数
全文


摘要